{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T11:22:00Z","timestamp":1793013720881,"version":"4.5.0"},"reference-count":27,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n IMPORTANCE<\/jats:title>\n Effectiveness of seasonal influenza vaccine must be assessed annually as influenza viruses evolve, requiring updated vaccine components. Evidence is limited for direct vaccine benefit in lowering risk of death following influenza virus infection.<\/jats:p>\n <\/jats:sec>\n \n OBJECTIVE<\/jats:title>\n To evaluate the association between current-season influenza vaccination and laboratory-confirmed influenza virus infection and, among persons with laboratory-confirmed influenza, the association with influenza-associated death.<\/jats:p>\n <\/jats:sec>\n \n DESIGN, SETTING, AND PARTICIPANTS<\/jats:title>\n A case-control analysis of California residents aged 6 months or older with influenza diagnostic testing ordered between October 1, 2024, and May 31, 2025, with data on diagnostic test result and 2024 to 2025 influenza vaccination. Influenza-associated deaths within 30 days of testing among persons with laboratory-confirmed influenza were identified from vital statistics records.<\/jats:p>\n <\/jats:sec>\n \n EXPOSURES<\/jats:title>\n Influenza vaccination from October 1, 2024, to May 31, 2025.<\/jats:p>\n <\/jats:sec>\n \n MAIN OUTCOMES AND MEASURES<\/jats:title>\n Associations were evaluated between 2024 to 2025 influenza vaccination and (1) laboratory-confirmed influenza, in which case individuals tested positive and control individuals tested negative for laboratory confirmed influenza; and (2) influenza-associated death, in which deaths were compared with surviving cases among persons with laboratory-confirmed influenza. Associations were assessed with mixed-effects logistic regression.<\/jats:p>\n <\/jats:sec>\n \n RESULTS<\/jats:title>\n Among 1\u202f106\u202f628 persons tested for laboratory-confirmed influenza (610\u202f093 female participants [55.1%]), 234\u202f715 were case individuals with laboratory-confirmed influenza (median [IQR] age, 28 [10-52] years) and 871\u202f913 were control individuals (median [IQR] age, 42 [19-67] years); 45\u202f441 influenza cases (19.4%) and 255\u202f605 control individuals (29.3%) had received 2024 to 2025 influenza vaccination. Vaccination was significantly associated with decreased likelihood of laboratory-confirmed influenza (estimated vaccine effectiveness, 40%; 95% CI, 39%-41%). Among persons with laboratory confirmed influenza, there were 801 influenza-associated deaths. Influenza-associated death among persons aged 65 years or older was associated with lower likelihood of influenza vaccination (adjusted odds ratio, 0.71; 95% CI, 0.60-0.84) compared with persons with nonfatal infection.<\/jats:p>\n <\/jats:sec>\n \n CONCLUSIONS AND RELEVANCE<\/jats:title>\n In this case-control study of estimated vaccine effectiveness, influenza vaccination was associated with decreased likelihood of laboratory-confirmed influenza and influenza-associated deaths among those with laboratory-confirmed influenza. Electronic laboratory reporting linked to immunization registry and vital statistics provide tools to assess vaccine effectiveness and risk of death, a rare influenza-associated outcome.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.17684","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:30:48Z","timestamp":1781105448000},"page":"e2617684","source":"Crossref","is-referenced-by-count":4,"title":["Influenza Vaccine and Associated Infection and Death in California, 2024 to 2025"],"prefix":"10.1001","volume":"9","author":[{"given":"Sophie","family":"Zhu","sequence":"first","affiliation":[{"name":"California Department of Public Health, Richmond"},{"name":"Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Quint","sequence":"additional","affiliation":[{"name":"California Department of Public Health, Richmond"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom\u00e1s M.","family":"Le\u00f3n","sequence":"additional","affiliation":[{"name":"California Department of Public Health, Richmond"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Sun","sequence":"additional","affiliation":[{"name":"California Department of Public Health, Richmond"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy J.","family":"Li","sequence":"additional","affiliation":[{"name":"California Department of Public Health, Richmond"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Yen","sequence":"additional","affiliation":[{"name":"California Department of Public Health, Richmond"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan","family":"Flannery","sequence":"additional","affiliation":[{"name":"National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sascha","family":"Ellington","sequence":"additional","affiliation":[{"name":"National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessie R.","family":"Chung","sequence":"additional","affiliation":[{"name":"National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Jain","sequence":"additional","affiliation":[{"name":"California Department of Public Health, Richmond"},{"name":"Now with San Francisco Department of Public Health, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Schechter","sequence":"additional","affiliation":[{"name":"California Department of Public Health, Richmond"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cora","family":"Hoover","sequence":"additional","affiliation":[{"name":"California Department of Public Health, Richmond"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin L.","family":"Murray","sequence":"additional","affiliation":[{"name":"California Department of Public Health, Richmond"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"issue":"34","key":"zoi260497r1","doi-asserted-by":"publisher","first-page":"529","DOI":"10.15585\/mmwr.mm7434a1","article-title":"Influenza-associated hospitalizations during a high severity season - influenza hospitalization surveillance network, United States, 2024-25 influenza season.","volume":"74","author":"O\u2019Halloran","year":"2025","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"zoi260497r3","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1093\/cid\/ciad677","article-title":"Vaccine effectiveness against influenza A\u2013associated hospitalization, organ failure, and death: United States, 2022\u20132023.","volume":"78","author":"Lewis","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"5","key":"zoi260497r4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7305a1","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices\u2014United States, 2024\u201325 influenza season.","volume":"73","author":"Grohskopf","year":"2024","journal-title":"MMWR Recomm Rep"},{"issue":"4","key":"zoi260497r5","doi-asserted-by":"publisher","first-page":"e184","DOI":"10.1093\/cid\/ciae658","article-title":"Influenza vaccine effectiveness against medically attended outpatients illness, United States, 2023-2024 season.","volume":"81","author":"Chung","year":"2025","journal-title":"Clin Infect Dis"},{"issue":"3","key":"zoi260497r6","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1093\/cid\/ciad704","article-title":"Vaccine effectiveness against pediatric influenza-A-associated urgent care, emergency department, and hospital encounters during the 2022-2023 season: VISION network.","volume":"78","author":"Adams","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"1","key":"zoi260497r7","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.vaccine.2015.11.016","article-title":"Assessment of influenza vaccine effectiveness in a sentinel surveillance network 2010-13, United States.","volume":"34","author":"Cowling","year":"2016","journal-title":"Vaccine"},{"issue":"2","key":"zoi260497r8","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2024.29.2.2300709","article-title":"Early influenza vaccine effectiveness estimates using routinely collected data, Alberta, Canada, 2023\/24 season.","volume":"29","author":"Smolarchuk","year":"2024","journal-title":"Euro Surveill"},{"issue":"8","key":"zoi260497r10","doi-asserted-by":"publisher","first-page":"175","DOI":"10.15585\/mmwr.mm7308a4","article-title":"Interim influenza vaccine effectiveness against laboratory-confirmed influenza\u2014California, October 2023\u2013January 2024.","volume":"73","author":"Zhu","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"zoi260497r11","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1093\/infdis\/jiaf248","article-title":"Estimating influenza vaccine effectiveness against laboratory-confirmed influenza using linked public health information systems, California, 2023-2024 season.","volume":"232","author":"Zhu","year":"2025","journal-title":"J Infect Dis"},{"issue":"2","key":"zoi260497r12","doi-asserted-by":"publisher","first-page":"61","DOI":"10.32614\/RJ-2010-017","article-title":"The RecordLinkage package: detecting errors in data.","volume":"2","author":"Sariyar","year":"2010","journal-title":"R J"},{"issue":"3","key":"zoi260497r13","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1093\/cid\/ciae597","article-title":"Influenza vaccine effectiveness against hospitalizations and emergency department or urgent care encounters for children, adolescents, and adults during the 2023\u20132024 season, United States.","volume":"81","author":"Tenforde","year":"2025","journal-title":"Clin Infect Dis"},{"issue":"4","key":"zoi260497r14","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2025.30.4.2500059","article-title":"Interim estimates of vaccine effectiveness against influenza A(H1N1)pdm09 and A(H3N2) during a delayed influenza season, Canada, 2024\/25.","volume":"30","author":"Separovic","year":"2025","journal-title":"Euro Surveill"},{"issue":"6","key":"zoi260497r15","doi-asserted-by":"publisher","first-page":"83","DOI":"10.15585\/mmwr.mm7406a2","article-title":"Interim estimates of 2024\u20132025 seasonal influenza vaccine effectiveness\u2014four vaccine effectiveness networks, United States, October 2024\u2013February 2025.","volume":"74","author":"Frutos","year":"2025","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"28","key":"zoi260497r17","doi-asserted-by":"publisher","first-page":"3678","DOI":"10.1016\/j.vaccine.2021.05.011","article-title":"Does influenza vaccination attenuate the severity of breakthrough infections? A narrative review and recommendations for further research.","volume":"39","author":"Ferdinands","year":"2021","journal-title":"Vaccine"},{"issue":"8","key":"zoi260497r18","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1093\/cid\/cix468","article-title":"Influenza vaccination modifies disease severity among community-dwelling adults hospitalized with influenza.","volume":"65","author":"Arriola","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"1","key":"zoi260497r19","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1136\/archdischild-2016-312165","article-title":"Live attenuated influenza vaccine (LAIV): recent effectiveness results from the USA and implications for LAIV programmes elsewhere.","volume":"103","author":"Pebody","year":"2018","journal-title":"Arch Dis Child"},{"key":"zoi260497r20","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofx111","article-title":"Live-attenuated influenza vaccine effectiveness in children from 2009 to 2015\u20132016: a systematic review and meta-analysis.","author":"Caspard","year":"2017","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"zoi260497r22","doi-asserted-by":"publisher","DOI":"10.1111\/irv.13087","article-title":"Investigating confounding in network-based test-negative design influenza vaccine effectiveness studies-experience from the DRIVE project.","volume":"17","author":"Stuurman","year":"2023","journal-title":"Influenza Other Respir Viruses"},{"issue":"2","key":"zoi260497r23","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1093\/ije\/dyi275","article-title":"Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors.","volume":"35","author":"Jackson","year":"2006","journal-title":"Int J Epidemiol"},{"issue":"28","key":"zoi260497r25","doi-asserted-by":"publisher","first-page":"21187","DOI":"10.2807\/1560-7917.ES2015.20.28.21187","article-title":"Estimating influenza vaccine effectiveness in Spain using sentinel surveillance data.","volume":"20","author":"Jimenez-Jorge","year":"2015","journal-title":"Euro Surveill"},{"issue":"1","key":"zoi260497r26","doi-asserted-by":"publisher","first-page":"e564","DOI":"10.1093\/cid\/ciac234","article-title":"Effects of confounding bias in coronavirus disease 2019 (COVID-19) and influenza vaccine effectiveness test-negative designs due to correlated influenza and COVID-19 vaccination behaviors.","volume":"75","author":"Doll","year":"2022","journal-title":"Clin Infect Dis"},{"key":"zoi260497r21","author":"Sun","year":"2023"},{"key":"zoi260497r2","unstructured":"US Centers for Disease Control and Prevention. Preliminary estimated flu disease burden 2024\u20132025 flu season. 2025. Accessed August 20, 2025. https:\/\/www.cdc.gov\/flu-burden\/php\/data-vis\/2024-2025.html"},{"key":"zoi260497r9","unstructured":"California Department of Public Health. Laboratory reporting letter for respiratory viruses, 2023. Accessed October 28, 2024. https:\/\/www. cdph.ca.gov\/Programs\/CID\/DCDC\/CDPH%20Document %20Library\/Laboratory_Reporting_Letter_COVID_Influenza_ RSC_Sept2023_Final.pdf"},{"key":"zoi260497r16","unstructured":"Zhu? S, Quint? J, Le\u00f3n? TM, . Interim influenza vaccine effectiveness against laboratory-confirmed influenza, California, October 2024\u2013January 2025. Presented at 2025 Advisory Committee for Immunization Practices Meeting; 2025; Atlanta, GA. Accessed May 2, 2026. https:\/\/www.cdc.gov\/acip\/downloads\/slides-2025-04-15-16\/03-zhu-influenza-508.pdf"},{"key":"zoi260497r24","unstructured":"Centers for Disease Control and Prevention. How CDC estimates the burden of seasonal flu in the United States. 2019. Accessed August 20, 2025. https:\/\/www.cdc.gov\/flu-burden\/php\/about\/how-cdc-estimates.html"},{"key":"zoi260497r27","unstructured":"California Department of Public Health. Respiratory virus weekly report week 16: April 13\u2013April 19, 2025. 2025. Accessed March 16, 2026. https:\/\/www.cdph.ca.gov\/Programs\/CID\/DCDC\/CDPH%20Document%20Library\/Respiratory-Viruses\/Respiratory-Virus-Report\/RespiratoryVirusReportWeek16.pdf"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2850136\/zhu_2026_oi_260497_1780432338.80088.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:30:51Z","timestamp":1781105451000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2850136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.17684","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]}}}